Last reviewed · How we verify
NCT03470779
Impact of Combined Psychotherapy and Physiotherapy Group Treatment Program for Survivors of Torture
NA trial testing Physiotherapy in Pain Syndrome in 30 participants. Completed in 1 January 2019.
15 November 2018
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 19 April 2018 |
| Primary completion | 15 November 2018 |
| Estimated completion | 1 January 2019 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Physiotherapy — full drug profile →
- Psychotherapy
Conditions studied
- Pain Syndrome — all drugs for Pain Syndrome →
- Disability Physical — all drugs for Disability Physical →
Sponsor
Northwestern University
Who can join
Adults 18 to 100, male only, with Pain Syndrome or Disability Physical. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess the impact and feasibility of an interdisciplinary group treatment approach, involving psychotherapy and physiotherapy, with survivors of torture that are incarcerated in a prison in Kurdistan, Iraq. The primary aim is to develop initial estimates of treatment effects on symptoms and poor functioning consistent with centralized pain and post-traumatic stress disorder, anxiety, and/or depression. The secondary aim is to assess the feasibility of studying this interdisciplinary treatment program in which local Kurdish psychotherapists and physiotherapists provide a 10-week intervention in a prison, in the Kurdish Sorani language, and to Kurdish participants that present with mental health symptoms, physical complaints, and poor functioning
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychological and social interventions for the prevention of mental disorders in people living in low- and middle-income countries affected by humanitarian crises.
Papola D, Purgato M, Gastaldon C, Bovo C, et al · · 2020 · cited 46× · PMID 32897548 · DOI 10.1002/14651858.cd012417.pub2
Verify or expand the search:
- PubMed search for NCT03470779
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Physiotherapy
Trials testing the same drug.
- NCT06815692 — Interdisciplinary Interventions After mTBI · not yet recruiting
- NCT07236424 — Effectiveness of Exercise, Walking, and Education on Mental Health, Mobility and Quality of Life in Elderly Residents of · NA · completed
- NCT07339410 — Physiotherapy to Improve Balance and Walking Capacity in Hemophilia · NA · completed
- NCT07156981 — Effects of Physiotherapy in Children With Hirschsprung's Disease · NA · not yet recruiting
- NCT07030764 — Comparison of Arthrogenic Muscle Inhibition (AMI) After ACL Reconstruction in Patients With Conventional Rehabilitation · NA · recruiting
Other recruiting trials for Pain Syndrome
Currently open trials in the same condition.
- NCT07421427 — Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome · NA · recruiting
- NCT06722014 — Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers · NA · recruiting
- NCT06884852 — Ultrasound-guided Multilevel Erectorspinae Plane Block Versus Thoracic Epidural Analgesia for Prevention of Post Mastect · NA · recruiting
- NCT06704698 — Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery · NA · recruiting
- NCT05805696 — Treatment and Mapping of Impostor Phenomenon · NA · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03470779 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 13 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03470779.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing